Mobius Therapeutics, LLC, today announced a voluntary recall of 2 lots of mitomycin for solution, 0.2 mg/vial, kit for ophthalmic use (Mitosol) because of the possibility that the affected lots may ...

For years ophthalmologists have been using the drug mitomycin C off-label to modulate wound healing during eye surgeries. In glaucoma filtering surgery, it’s known to prevent post-operative scarring ...

Please provide your email address to receive an email when new articles are posted on . Mitomycin C treatment was effective in treating corneal conjunctival intraepithelial neoplasia in a clinical ...

We retrospectively studied the efficacy and safety of different surgical approaches to treating pediatric limbal dermoids with regard to intra and postoperative complications. The data of 12 ...

SAN FRANCISCO, California — In patients with glaucoma, mitomycin C administered with intra-Tenon injection results in lower intraocular pressure and fewer medications after surgery than mitomycin C ...

Mobius Therapeutics announced that it is conducting a voluntary recall of two lots of Mitosol (mitomycin for solution), 0.2mg/vial Kit for Ophthalmic Use due to the possibility that the affected lots ...

Purpose To evaluate the safety and efficacy of trabeculectomy with or without mitomycin-C (MMC) in the management of glaucoma in aphakia and pseudophakia following congenital cataract surgery.

Editor’s note: Ophthalmologists are frequently consulted to evaluate and care for patients with facial injuries, especially lacerations. In addition, many ophthalmologists feel comfortable about ...

TUCSON, Ariz. & LONDON--(BUSINESS WIRE)--Radiance Therapeutics, Inc. (RadianceTx®) is pleased to announce the expansion of its core team: Abigail Mackrill, formerly of Ophthalmology Futures Forums and ...